SHZ · 300725.SZ
PharmaBlock Sciences (Nanjing), Inc.
CN¥44.80+CN¥2.10 (+4.92%)
PharmaBlock Sciences (Nanjing), Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.15% below the high.
Loading market information…
SHH · 688277.SS · CNY
Stock price, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
TINAVI Medical Technologies Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow TINAVI Medical Technologies Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TINAVI Medical Technologies Co., Ltd. specializes in the entire lifecycle of orthopedic robotic technology, encompassing its research, development, production, and practical clinical application. The company's flagship offering is TiRobot, a sophisticated robotic system engineered to assist in orthopedic surgical procedures related to both spine and trauma. Established in 2010, TINAVI Medical Technologies operates from its headquarters in Beijing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Apr 28, 2025 |
| -CN¥0.03 |
| CN¥58.58M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥44.80+CN¥2.10 (+4.92%)
PharmaBlock Sciences (Nanjing), Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.15% below the high.
CN¥12.46-CN¥0.04 (-0.32%)
Beijing Strong Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.37% below the high.
CN¥12.29+CN¥0.17 (+1.4%)
Jiangsu Kanion Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.01% below the high.
CN¥11.85+CN¥0.51 (+4.5%)
Sunflower Pharmaceutical Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 23.15% below the high.
CN¥11.84+CN¥0.10 (+0.85%)
Edan Instruments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.52% below the high.
CN¥9.22+CN¥0.23 (+2.56%)
Truking Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 32.65% below the high.
CN¥10.76-CN¥0.49 (-4.36%)
Shenzhen YHLO Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.71% below the high.
CN¥8.98-CN¥0.02 (-0.22%)
Maccura Biotechnology Co.Ltd’s quoted price sits in the lower half of its reported 52-week range, 36.76% below the high.
